Vincenzo Teneggi

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi request reprint Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal
    Vincenzo Teneggi
    GlaxoSmithKline SpA, Medicine Research Centre, Via A Fleming N 4, 37135 Verona, Italy
    Psychopharmacology (Berl) 164:177-87. 2002
  2. ncbi request reprint Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h
    Vincenzo Teneggi
    GlaxoSmithKline, Via A Fleming N 4, Verona 37135, Italy
    Psychopharmacology (Berl) 183:1-12. 2005
  3. pmc Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving
    Vincenzo Teneggi
    GlaxoSmithKline, Via A Fleming 2, 37135 Verona, Italy
    Br J Clin Pharmacol 54:407-14. 2002
  4. ncbi request reprint EEG power spectra and auditory P300 during free smoking and enforced smoking abstinence
    Vincenzo Teneggi
    Discovery Medicine, GlaxoSmithKline SpA, Via Fleming 4, 37135, Verona, Italy
    Pharmacol Biochem Behav 77:103-9. 2004
  5. ncbi request reprint Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography
    Timothy J Carroll
    Department of Medical Physics, University of Wisconsin, Madison, USA
    J Cereb Blood Flow Metab 22:1149-56. 2002

Collaborators

  • Timothy J Carroll
  • Valerie Treyer
  • Lisa Squassante
  • Alan Bye
  • Gustav K von Schulthess
  • Mathieu Jobin
  • Liqun Wang
  • Thomas F Hany
  • Alfred Buck
  • Cyrill Burger

Detail Information

Publications5

  1. ncbi request reprint Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal
    Vincenzo Teneggi
    GlaxoSmithKline SpA, Medicine Research Centre, Via A Fleming N 4, 37135 Verona, Italy
    Psychopharmacology (Berl) 164:177-87. 2002
    ..Research on the effects of nicotine abstinence and nicotine replacement has not provided consistent information about the impact of replacement therapies on tobacco withdrawal and craving...
  2. ncbi request reprint Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h
    Vincenzo Teneggi
    GlaxoSmithKline, Via A Fleming N 4, Verona 37135, Italy
    Psychopharmacology (Berl) 183:1-12. 2005
    ..Sustained-release (SR) bupropion enhances quit rates of smokers, generally decreases tobacco withdrawal, and in some studies, reduces craving...
  3. pmc Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving
    Vincenzo Teneggi
    GlaxoSmithKline, Via A Fleming 2, 37135 Verona, Italy
    Br J Clin Pharmacol 54:407-14. 2002
    ....
  4. ncbi request reprint EEG power spectra and auditory P300 during free smoking and enforced smoking abstinence
    Vincenzo Teneggi
    Discovery Medicine, GlaxoSmithKline SpA, Via Fleming 4, 37135, Verona, Italy
    Pharmacol Biochem Behav 77:103-9. 2004
    ..Auditory P300 amplitude and latency were unaffected by smoking abstinence. Resting EEG, but not auditory P300, was sufficiently sensitive to detect changes during enforced smoking abstinence, and EEG bands had different temporal changes...
  5. ncbi request reprint Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography
    Timothy J Carroll
    Department of Medical Physics, University of Wisconsin, Madison, USA
    J Cereb Blood Flow Metab 22:1149-56. 2002
    ..Until reproducibility is improved and vascular artifacts are efficiently removed, MR is not suitable for reliable quantitative perfusion measurements...